Panel Says Go. Time to Push.

In Baseline Drawn, nine tubes left my arm and an ECG ran on my kitchen counter. Twenty-four hours later, twenty-six of twenty-seven markers landed. Only Free Testosterone is still outstanding, and we can Vermeulen-estimate it from what we have. The baseline is functionally locked.

The read surprised me. I walked into this expecting to see damage — two months of weight gain stacked on top, too many Cuban Cohibas, and the gym schedule slipping. What the lab showed was a body built on a much stronger foundation than the last two months implied. That changes the decision that comes next.

The ECG read — first, the heart

The 10-second tracing came back from Dr. César Niño, Cardiólogo (RM 5-3346-13). Classifier: NORMAL 80%. Doctor note, verbatim: "Bradicardia sinusal con frecuencia cardiaca de 55 lpm. Conducción AV con PR normal y QRS normal. Progresión normal QRS. rSr en DIII. Eje normal. Repolarización y QTc normal."

The bradycardia at 55 bpm is the interesting number. In a generic sedentary adult it would be a yellow flag. In my context — the day after a deep-clean night, with Oura registering HRV 58 ms and nightly resting HR collapsed from 75 → 65 — it is the autonomic baseline finally surfacing without artificial stimulation. No AV block, no ST changes, QTc a comfortable 380 ms. The electrical system is clean and the foundation is better than it had a right to be.

The green systems — almost everything

The blood panel can be split cleanly into two groups. Group one is the systems that came back pristine. It is a much bigger group than I expected.

The liver result is the headline. ALT 19, AST 18. Some longevity clinics target ALT <20 as their "health marker." After two months of weight gain plus nightly cigars, the statistical expectation is fatty-liver infiltration, elevated enzymes, early fibrotic signal. I have none of that. The liver is operating like a twenty-five-year-old's — baby-liver territory. That one read removes an entire class of concern and opens the gate for compound-metabolism protocols that would otherwise need months of prep work.

The metabolic panel is the second headline. HOMA-IR 1.78 with fasting insulin 8.7 and fasting glucose 84. Below 2.0 is the biohacker target zone for insulin sensitivity. Despite two months of lifestyle drift, my metabolic machinery is functioning the way it's supposed to. The organ that drives most of the metabolic disease in modern men — an insulin system that has given up — is still fully online. The HbA1c flag of 5.7% is almost certainly a beta-thalassemia minor trait confound (my Balkan heritage, MCV 85.3), not real dysglycemia.

Pituitary works. Testes work. Thyroid works. Adrenals work. Kidneys work (with an Animal Pak asterisk — more below). Iron is clean. Vitamin D is sufficient. CBC shows zero inflammation signal. The body under the two-month drift is a much healthier machine than the drift suggested.

The flags — and why they are fixable

The second group is the markers that are off. Every single one of them traces back to the same story: the last two months. Sedentary drift, too many late meals, too many Cuban Cohibas, Animal Pak stacked nightly, and body fat that crept up while the gym schedule slipped.

The pattern is consistent. Nothing here is organ damage. Everything here is lifestyle exhaust. Atherogenic Index 4.6 is not the signature of a failing cardiovascular system — it is the signature of a guy who stopped moving and started eating comfortably, whose HDL sank from lack of cardio and tobacco exposure and whose triglycerides crept up from refined carbs and late-night eating. hs-CRP 2.8 is chronic low-grade inflammation from the same drivers. HbA1c 5.7% is almost certainly artifact. E2 low-end is the sleeper finding, and it matters for how any hormonal protocol is designed (no prophylactic aromatase inhibitor — it would crash me).

Every one of these markers responds to the protocol I'm already running: weight loss, clean eating, more movement, continued distance from tobacco smoke. Most will re-test in a significantly different range at the 12-week redraw without any compound intervention at all.

The unexpected find: IGF-1 above range

One number was not on the expected list. IGF-1 came back at 251.30 ng/mL. The reference ceiling is 230. In my forties, the typical IGF-1 sits somewhere between 100 and 190. Mine is running 10% above the upper end of the adult range.

IGF-1 — Insulin-like Growth Factor 1 — is the liver-produced mirror of pituitary Growth Hormone output. GH itself is impossible to measure usefully (pulsatile, 20-minute half-life). IGF-1 is stable over ~15 hours and is the practical readout for how much GH activity the body is producing. A 251 here is, quite literally, a natural HGH output that most of my age cohort would pay thousands of dollars per month to achieve with injections.

The clinically-important step was ruling out the only pathological cause: acromegaly (a pituitary adenoma secreting excess GH). The symptom checklist is specific — enlarging hands, feet, jaw, teeth spreading, new sleep apnea, voice changes, excessive sweating, ring size or shoe size creep. I have none of them. No clinical signs, none in the last several years. The confirmation comes on Saturday with the doctor's physical exam.

With acromegaly ruled out, the remaining explanations are benign and mostly favorable:

• Natural strong-axis phenotype. Some men keep producing GH like 30-year-olds well into their 40s. This is what longevity medicine looks for.
• The Animal Pak stack. The full Animal Pak line I've been running contains glandular and liver-extract complexes along with amino acid loaders that modestly push GH output. Combined with a dairy-heavy diet, exogenous IGF-1 signaling is on the list of drivers. A 4-week supplement-and-dairy washout before the next draw will isolate how much of the 251 is "me" versus "me on Animal Pak."
• Sober rebound. Cuban cigars and long-term lifestyle stress suppress IGF-1 output. Cleaning that up unmasks the real baseline. There's likely a genuine bounce happening here.

This is what biohackers call a premium problem: your body is producing too much of a thing that everyone else is chasing. It also has one concrete protocol implication — it takes GH-releasing peptides (CJC-1295, Ipamorelin, MK-677, HGH itself) off the table until the retest clarifies the baseline. Stacking a GH stimulator on top of an already-elevated axis is the kind of dumb-smart move a biohacker should never make.

Three paths, three very different lives

When a panel lands this clean, the intervention menu splits into three categories. I am not picking between "do nothing" and "do everything." I am picking between three tiers that each produce a very different man at 46.

Path 1 is where a conservative endocrinologist would default, and it is a legitimate choice. Path 3 is where the dark-corner-of-the-gym Instagram influencer defaults, and it is a terrible choice at any age, and the wrong choice at mine. Path 2 is the one almost nobody talks about honestly. It is what elite longevity practices actually run for clients who want visible results without accepting organ damage.

The choice: Path 2 — Max animal, healthy ceiling

I'm going with Path 2. The decision comes from three things the panel revealed:

1. My foundation supports it. Liver pristine, insulin-sensitive, GH axis already running hot, pituitary and adrenal clean, no CV electrical damage. The body can absorb a well-designed hormonal protocol without any of the common failure modes.
2. The cost of Path 3 is non-negotiable. I don't need the IFBB stage. I want to look genuinely athletic and strong, not monstrous. Trenbolone and Deca and HGH cycles give a short-term aesthetic at a long-term organ cost I'm not willing to pay. A lifetime of sub-optimal heart function is not a trade I take.
3. Path 1 leaves performance on the table. Enclomiphene-first is the right move if fertility is non-negotiable or if you want full reversibility. Neither is a priority for me, and I'm ready to make a lifetime commitment in exchange for a meaningful step up in Free T, recovery, training capacity, and body composition.

The protocol I'll bring to the consult

This is what my research says Path 2 should look like for someone with my specific numbers. It is a research draft, not a prescription. The doctor proposes. I arrive with informed priors, not a blank slate.

The shoulder — biological layer now

Context for the peptide choice: I had shoulder surgery. The physio phase is done — mechanical rehabilitation accomplished what mechanical rehabilitation accomplishes. Range of motion is restored, strength is back. What comes next is the biological layer.

What mechanical rehab cannot do is remodel the tissue that scarred down during surgical healing. That is exactly what the BPC-157 + TB-500 stack is designed for. Localized subQ injections near the shoulder, 6-week cycles, combined with a fresh MRI to confirm the current post-operative state before deciding on PRP (platelet-rich plasma) as a potential next layer. The shoulder becomes the canary for the peptide stack — measurable ROM and pain reduction on a known tissue defect is the cleanest possible feedback signal.

Hardcore regenerative interventions — stem cells, exosomes — stay on the shelf unless the biological layer plateaus. The principle holds everywhere on this plan: take the smallest effective intervention, measure, and escalate only when the data justifies it.

Saturday, 07:30 — Dr. José Barrera

Saturday morning at 07:30 I'm on a video call with Dr. José Barrera at TRT Colombia. I've already sent him the full bloodwork PDF and this research draft, so the call starts with shared context — he's seen the 27 markers, the ECG, the IGF-1 finding, the three-path analysis, and my preferred direction. The call is the clinical conversation, not the intake. He'll do the acromegaly symptom check, look at the E2 low-end finding, decide how he wants to sequence TRT versus enclomiphene-first, and propose his protocol.

Consultation fee is 350,000 COP and includes the prescription and a travel letter if I want to carry the compounds out of the country. Fair for an hour with a clinician who already knows the case before the call starts.

I am not locked into the exact doses or compounds above. I am locked into the direction: Path 2, max animal with a healthy ceiling and quarterly monitoring. The doctor gets to tune the knobs. My job is to walk in with enough context to recognize a cookie-cutter protocol if one gets offered (it won't — TRT Colombia is the clinic that sent a 19-hour response to the litmus test) and enough humility to defer on the places where clinical judgment beats biohacker reading.

The next post in this series will be the follow-up: what Dr. Barrera actually proposes, what I accept and why, and the final locked-in starting protocol with Day 1 dosing. Then the 12-week redraw clock starts.

Why Path 2, not Path 3

The biochemistry supports pushing the upper end of safe optimization. It doesn't support the pro-bodybuilder compound rack. Path 3's cosmetic ceiling is real, but so is the organ cost — hypertrophy, renal strain, hepatic toxicity, destroyed lipids, shortened lifespan. I'm not trading the first for the second.

Path 1 is the right move if fertility was non-negotiable or I wanted full reversibility. Neither applies here. TRT + hCG preserves the testicular axis and the fertility window while actually moving T, recovery, and body composition.

The research above is prep. Saturday is the consult. The follow-up post will cover the protocol we land on. The 12-week redraw is how I'll know it worked.

Related Reading

• Baseline Drawn: One Clean Night, Blood on the Table
• Choosing a Biohacking Clinic in Medellín
• The Biohacking Litmus Test
• What Is Biohacking?